Catalyst Wire Dossier Catalyst Wire Dossier

HL-1186 Tablet

HL-1186 · Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HL-1186 Tablet, covering 2025-12-22 to 2025-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Pain Management in Abdominal Surgery [Phase 2]

See pricing